Expert Review of Precision Medicine and Drug Development
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.5 | Q4 | 19.9% | 0.250 | Q3 | 36.7% |
| 2024 | 1.2 | Q4 | 17.8% | 0.216 | Q4 | 33.8% |
| 2023 | 1.0 | Q4 | 17.9% | 0.257 | Q3 | 43.9% |
| 2022 | 1.2 | 17.5% | 0.317 | Q3 | 52.4% | |
| 2021 | — | 24.0% | 0.329 | Q3 | 54.2% | |
| 2020 | — | — | 0.387 | Q3 | 58.4% | |
| 2019 | — | — | 0.511 | Q2 | 68.2% | |
| 2018 | — | — | 0.355 | Q3 | 55.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2380-8993
region
Western Europe
coverage
2016-2025